110 related articles for article (PubMed ID: 17321054)
1. Role of tissue-plasminogen activator (t-PA) in a mouse model of neonatal white matter lesions: interaction with plasmin inhibitors and anti-inflammatory drugs.
Leroux P; Hennebert O; Legros H; Laudenbach V; Carmeliet P; Marret S
Neuroscience; 2007 May; 146(2):670-8. PubMed ID: 17321054
[TBL] [Abstract][Full Text] [Related]
2. Ontogenic study of the influence of tissue plasminogen activator (t-PA) in neonatal excitotoxic brain insult and the subsequent microglia/macrophage activation.
Hennebert O; Laudenbach V; Laquerriere A; Verney C; Carmeliet P; Marret S; Leroux P
Neuroscience; 2005; 130(3):697-712. PubMed ID: 15590153
[TBL] [Abstract][Full Text] [Related]
3. Role of tissue-derived plasminogen activator (t-PA) in an excitotoxic mouse model of neonatal white matter lesions.
Hennebert O; Marret S; Carmeliet P; Gressens P; Laquerrière A; Leroux P
J Neuropathol Exp Neurol; 2004 Jan; 63(1):53-63. PubMed ID: 14748561
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective effects vary across nonsteroidal antiinflammatory drugs in a mouse model of developing excitotoxic brain injury.
Leroux P; Hennebert C; Catteau J; Legros H; Hennebert O; Laudenbach V; Marret S
Neuroscience; 2010 May; 167(3):716-23. PubMed ID: 20188153
[TBL] [Abstract][Full Text] [Related]
5. Glucocorticoid treatment in an ischaemic-like excitotoxic model of periventricular leucomalacia in mice.
Arquié C; Leroux P; Bodenant C; Laquerrière A; Marpeau L; Marret S
BJOG; 2002 Sep; 109(9):989-96. PubMed ID: 12269694
[TBL] [Abstract][Full Text] [Related]
6. Function of tissue-type plasminogen activator releaser on vascular endothelial cells and thrombolysis in vivo.
Ueshima S; Matsuno H; Hayashi M; Horibuchi K; Okada K; Fukao H; Uematsu T; Matsuo O
Thromb Haemost; 2002 Jun; 87(6):1069-74. PubMed ID: 12083488
[TBL] [Abstract][Full Text] [Related]
7. The effect of tissue type-plasminogen activator deletion and associated fibrin(ogen) deposition on macrophage localization in peritoneal inflammation.
Cook AD; Vlahos R; Massa CM; Braine EL; Lenzo JC; Turner AL; Way KJ; Hamilton JA
Thromb Haemost; 2006 Apr; 95(4):659-67. PubMed ID: 16601837
[TBL] [Abstract][Full Text] [Related]
8. Influence of t-pA and u-PA on adipose tissue development in a murine model of diet-induced obesity.
Morange PE; Bastelica D; Bonzi MF; Van Hoef B; Collen D; Juhan-Vague I; Lijnen HR
Thromb Haemost; 2002 Feb; 87(2):306-10. PubMed ID: 11858492
[TBL] [Abstract][Full Text] [Related]
9. Effects of repeated dizocilpine treatment on adult rat behavior after neonatal lesions of the entorhinal cortex.
Harich S; Koch M; Schwabe K
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):816-27. PubMed ID: 18221827
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotection of the developing brain by systemic administration of vasoactive intestinal peptide derivatives.
Gressens P; Besse L; Robberecht P; Gozes I; Fridkin M; Evrard P
J Pharmacol Exp Ther; 1999 Mar; 288(3):1207-13. PubMed ID: 10027860
[TBL] [Abstract][Full Text] [Related]
11. Modulation of sympathetic activity by tissue plasminogen activator is independent of plasminogen and urokinase.
Schaefer U; Vorlova S; Machida T; Melchor JP; Strickland S; Levi R
J Pharmacol Exp Ther; 2007 Jul; 322(1):265-73. PubMed ID: 17429057
[TBL] [Abstract][Full Text] [Related]
12. Rt-PA causes a significant increase in endogenous u-PA during experimental focal cerebral ischemia.
Burggraf D; Martens HK; Wunderlich N; Jäger G; Hamann GF
Eur J Neurosci; 2004 Dec; 20(11):2903-8. PubMed ID: 15579144
[TBL] [Abstract][Full Text] [Related]
13. Role of tissue plasminogen activator in the sensitization of methamphetamine-induced dopamine release in the nucleus accumbens.
Fukakusa A; Nagai T; Mizoguchi H; Otsuka N; Kimura H; Kamei H; Kim HC; Nabeshima T; Takuma K; Yamada K
J Neurochem; 2008 Apr; 105(2):436-44. PubMed ID: 18036193
[TBL] [Abstract][Full Text] [Related]
14. Activated protein C reduces endotoxin-induced white matter injury in the developing rat brain.
Yesilirmak DC; Kumral A; Baskin H; Ergur BU; Aykan S; Genc S; Genc K; Yilmaz O; Tugyan K; Giray O; Duman N; Ozkan H
Brain Res; 2007 Aug; 1164():14-23. PubMed ID: 17644074
[TBL] [Abstract][Full Text] [Related]
15. Thiorphan, a neutral endopeptidase inhibitor used for diarrhoea, is neuroprotective in newborn mice.
Medja F; Lelièvre V; Fontaine RH; Lebas F; Leroux P; Ouimet T; Saria A; Rougeot C; Dournaud P; Gressens P
Brain; 2006 Dec; 129(Pt 12):3209-23. PubMed ID: 17028311
[TBL] [Abstract][Full Text] [Related]
16. The effects of dexmedetomidine on perinatal excitotoxic brain injury are mediated by the alpha2A-adrenoceptor subtype.
Paris A; Mantz J; Tonner PH; Hein L; Brede M; Gressens P
Anesth Analg; 2006 Feb; 102(2):456-61. PubMed ID: 16428542
[TBL] [Abstract][Full Text] [Related]
17. Irsogladine maleate inhibits angiogenesis in wild-type and plasminogen activator-deficient mice.
Ren CJ; Ueda F; Roses DF; Harris MN; Mignatti P; Rifkin DB; Shapiro RL
J Surg Res; 1998 Jul; 77(2):126-31. PubMed ID: 9733598
[TBL] [Abstract][Full Text] [Related]
18. Optimized thrombolysis of cerebral clots with tissue-type plasminogen activator in a rabbit model of embolic stroke.
Thomas GR; Thibodeaux H; Bennett WF; Refino CJ; Badillo JM; Errett CJ; Zivin JA
J Pharmacol Exp Ther; 1993 Jan; 264(1):67-73. PubMed ID: 8423552
[TBL] [Abstract][Full Text] [Related]
19. Age-dependent neonatal intracerebral hemorrhage in plasminogen activator inhibitor 1 knockout mice.
Leroux P; Omouendze PL; Roy V; Dourmap N; Gonzalez BJ; Brasse-Lagnel C; Carmeliet P; Leroux-Nicollet I; Marret S
J Neuropathol Exp Neurol; 2014 May; 73(5):387-402. PubMed ID: 24709679
[TBL] [Abstract][Full Text] [Related]
20. T3 replacement does not prevent excitotoxic cell death but reduces developmental neuronal apoptosis in newborn mice.
Sárközy G; Griesmaier E; He X; Kapelari K; Urbanek M; Simbruner G; Gressens P; Keller M
Eur J Paediatr Neurol; 2007 May; 11(3):129-35. PubMed ID: 17222575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
